Revelation Partners is an investment firm specializing in direct and fund of fund investments.
Business Model:
Revenue: $0
Employees: 0-0
Address: 255 California Street
City: San Francisco
State: CA
Zip: 94111
Country: US
Revelation Partners invests broadly across healthcare sectors with a focus on commercial companies with proven business models or companies with novel technologies that have clear clinical and regulatory pathways. They actively invest in the following healthcare verticals - medical devices, biopharmaceuticals, healthcare IT and healthcare services.
Contact Phone:
+14159057226
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2023 | Carrum Health | Series B | 0 |
5/2020 | Arterys | Series C | 28M |
9/2018 | Providence Medical Technology | Equity | 25M |
6/2017 | Vertos Medical | Venture Round | 0 |
12/2020 | SomaLogic | Series A | 0 |
7/2020 | Evidation Health | Series D | 45M |
4/2022 | IntelyCare | Series C | 0 |
8/2020 | NeuroPace | Venture Round | 33M |
3/2022 | Gravie | Series E | 0 |
10/2021 | Click Therapeutics | Series B | 0 |
1/2021 | SetPoint Medical | Venture Round | 0 |
2/2022 | Endeavor BioMedicines | Series B | 101M |
5/2022 | Aspen Neuroscience | Series B | 0 |
8/2021 | Genome Medical | Series C | 0 |
4/2023 | Vedanta Biosciences | Series E | 0 |
3/2021 | Nuvolo | Series C | 32M |
3/2022 | Gravie | Series E | 75M |
11/2021 | HotSpot Therapeutics | Series C | 0 |
3/2021 | Gravie | Series D | 0 |
3/2021 | Gravie | Series D | 28M |
10/2021 | SPR Therapeutics | Series D | 0 |
10/2016 | ClearCorrect | Private Equity Round | - |
5/2020 | Syapse | Series D | 30M |
7/2020 | Genome Medical | Series B | 0 |
6/2022 | Dren Bio | Series B | 0 |
1/2020 | Arcadia io | Venture Round | 29.5M |
6/2022 | Dren Bio | Series B | 0 |
5/2022 | Aspen Neuroscience | Series B | 0 |
4/2022 | IntelyCare | Series C | 0 |
3/2022 | Gravie | Series E | 0 |
2/2022 | Endeavor BioMedicines | Series B | 0 |
11/2021 | HotSpot Therapeutics | Series C | 0 |
10/2021 | Click Therapeutics | Series B | 0 |
10/2021 | SPR Therapeutics | Series D | 0 |
8/2021 | Genome Medical | Series C | 0 |
3/2021 | Gravie | Series D | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|